AA

Adial Pharmaceuticals (NASDAQ: ADIL)

Request removal

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company's lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) and is currently being investigated in the Company's landmark ONWARD™ Phase 3 clinical trial for the potential treatment of AUD in subjects with certain target genotypes, which are to be identified using the Company's proprietary companion diagnostic genetic test. A Phase 2b clinical trial of AD04 for the treatment of AUD showed promising results in reducing frequency of drinking, quantity of drinking and heavy drinking (all with statistical significance), and no overt safety concerns (there were no statistically significant serious adverse events reported). AD04 is also believed to have the potential to treat other addictive disorders such as Opioid Use Disorder, gambling, and obesity. The Company is also developing adenosine analogs for the treatment of pain and other disorders.

Get valid emails for people working at Adial Pharmaceuticals (NASDAQ: ADIL) and 200M other companies
20 free emails each month. No credit card required.
500M
Business Profiles
20M
Company Profiles
200M
Email addresses
98%+
Email Delivery
Adial Pharmaceuticals (NASDAQ: ADIL)'s headquarter address
Line 1: 1108 seminole trail, charlottesville, virginia, united states
Line 2: 1108 Seminole Trl
Adial Pharmaceuticals (NASDAQ: ADIL)'s industries
pharmaceuticals
Adial Pharmaceuticals (NASDAQ: ADIL)'s technology
Amcharts JS Library Apache Google Analytics Google Cloud Hosting Google Font API Google Tag Manager Gravity Forms Microsoft Office 365 Mobile Friendly Nginx Outlook Vimeo WP Engine WordPress.org YouTube reCAPTCHA
People working at Adial Pharmaceuticals (NASDAQ: ADIL)
CS
Cary Claiborne Sr.
Board Member - Non Executive
Charlottesville, Virginia, United States
PJ
Prof. Dr. Bankole Johnson
Founder & CMO, Adial
Charlottesville, Virginia, United States
SV
Schuyler V.
Vice President, Development
Charlottesville, Virginia, United States
JM
John Rothwell Martin
Chief Legal Officer/General Counsel
Charlottesville, Virginia, United States
JD
Julien Dimastromatteo
Vice President Research
Charlottesville, Virginia, United States
JT
Joseph Truluck
COO/CFO
Charlottesville, Virginia, United States
DM
Dick Leary, MBA
Director, Strategic Projects
Charlottesville, Virginia, United States
TG
Tony D. Goodman
Board Member, Non Executive Director
Charlottesville, Virginia, United States
AT
Andrew Taubman
VP Corporate Development and Special Projects
AA
Adil Afridi
Marketing Manager
Charlottesville, Virginia, United States
You can find 11 people working at Adial Pharmaceuticals (NASDAQ: ADIL) on FinalScout. Create a free account to view details including email addresses.
Scrape emails from LinkedIn for free
20 free emails each month. No credit card required.
Regular search results
Search for leads on linkedin.com and scrape the search results
Sales Navigator search results
Search for leads in LinkedIn sales navigator and scrape the search results
Group members
Scrape members from any LinkedIn group without joining it
Event attendees
Scrape event attendees from any LinkedIn event
Directory